← All comparisons
Head-to-head · FAERS comparison

Ramipril vs Verapamil: side effects in FDA adverse event reports

Ramipril profile · Verapamil profile · data 2026-09-14
How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

RamiprilVerapamil
Drug classAngiotensin Converting Enzyme Inhibitor–
Brand names–Verapamil Hydrochloride
FAERS reports123,1364,242
Serious93%91%
Death outcome13,282948
Boxed warningYes FETAL TOXICITY WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning When pregnancy is detected, discontinue ramipril as soon as pNo

Signals both drugs share

No strong shared signal after removing coding and lab terms.

Labeled signals distinctive to Ramipril

Labeled signals distinctive to Verapamil

Common questions

Which has more reported side effects, Ramipril or Verapamil?

Ramipril has 123,136 FAERS reports and Verapamil 4,242. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (93% vs 91%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Ramipril and Verapamil share?

They share no strong flagged signal after artifacts and lab terms are removed.

Is Ramipril or Verapamil safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.